Upload Image (Max 20MB per Image)
APP Pharmaceuticals, a Fresenius Kabi Company, has purchased three products, Benztropine Mesylate Injection, Levetiracetam Injection and Tranexamic Acid Injection, from Nexus Pharmaceuticals. As per the agreement, APP acquires complete ...
Tags: APP Pharmaceuticals, Benztropine Mesylate Injection